;or a pharmaceutically effective salt or ester thereof alone or in combination with L-DOPA to provide a synergistic effect, thereby providing methods of (1) treating patients with Parkinson's Disease for whom L-DOPA is no longer effective, (2) treating patients with Parkinson's Disease who developed dyskinesia due to L-DOPA, (3) treating patients with Parkinson's Disease who have are receiving deep brain stimulation and (4) treating patients with Parkinson's Disease whose symptoms interfere with activities of daily living."/>
公开/公告号US2021220349A1
专利类型
公开/公告日2021-07-22
原文格式PDF
申请/专利权人 VERSI GROUP LLC;
申请/专利号US202117198479
申请日2021-03-11
分类号A61K31/495;A61P25/14;A61P25/16;
国家 US
入库时间 2022-08-24 20:04:21